Last reviewed · How we verify

NCT06220292

Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia

Withdrawn NA Last updated 5 March 2024
What this trial tests

NA trial testing Conventional Care in Alzheimer Disease. Withdrawn.

Timeline
30 January 2024
Primary endpoint
30 July 2024
15 August 2024

Quick facts

Lead sponsorZeng Changhao
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date30 January 2024
Primary completion30 July 2024
Estimated completion15 August 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zeng Changhao — full company profile →

Who can join

Adults 18 to 85, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received Intermittent Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for enteral nutrition support. Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life after treatment are compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Conventional Care

Trials testing the same drug.

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

Other Zeng Changhao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06220292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing